ST眾泰(000980.SZ):擬投建智能網聯新能源汽車研發及生產基地項目
格隆匯8月19日丨ST眾泰(000980.SZ)公佈,公司及公司的全資下屬企業湖南江南汽車製造有限公司(簡稱“江南製造”)與重慶市璧山區人民政府於2022年8月19日簽署了《智能網聯新能源汽車研發及生產基地項目合作協議》。經公司和璧山區政府雙方友好協商,達成共識,就雙方在智能網聯汽車方面的合作簽署合作協議,在智能網聯新能源汽車項目開發建設領域構建深度合作關係。公司下屬企業湖南江南汽車製造有限公司重慶分公司在重慶璧山區擁有年產10萬輛乘用車的生產能力,並經過政府相關主管部門的批覆。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.